INNOVATIVE BIOTHERAPIES, INC.

Company Information
Address 650 AVIS DR # 300
ANN ARBOR, MI, 48108-9649


Information

DUNS: 143681240

# of Employees: 12


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. L-MOD Therapy: Leukocyte Immunomodulation during Cardiopulmonary Bypass

    Amount: $588,700.00

    DESCRIPTION provided by applicant The Problem Cardiovascular disease is the leading cause of death in the Western world In the US nearly coronary artery bypass surgeries are performed an ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  2. Biomimetic Membrane Device for Therapeutic Application in Chronic Heart Failure

    Amount: $655,205.00

    DESCRIPTION provided by applicant Cardiovascular disease is the leading cause of mortality in the US accounting for of all deaths Chronic Heart Failure CHF is now understood to be a multi ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Fiber design and assessment for development of a novel biomimetic medical device

    Amount: $323,816.00

    DESCRIPTION provided by applicant The Selective Cytopheretic Device SCD is an extracorporeal medical device targeted to treat patients with inflammatory disease indications As patient blood pass ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  4. Immunomodulatory Device for Treatment of Pediatric Acute Renal Failure Patients

    Amount: $364,723.00

    DESCRIPTION (provided by applicant): The Problem: The lack of devices specifically designed for pediatric applications has been recognized by directives in the Pediatric Medical Device Safety and Impr ...

    SBIRPhase I2013Department of Health and Human Services
  5. Selective Cytopheresis Therapy in Systemic Inflammatory Response Syndrome

    Amount: $1,432,240.00

    DESCRIPTION (provided by applicant): Leukocytes (LE) are major contributors to the pathogenesis and progression of many clinical inflammatory disorders, including the systemic inflammatory response sy ...

    SBIRPhase II2012Department of Health and Human Services
  6. Enhanced Propagation of Adult Human Renal Epithelial Cells Allowing for Commercia

    Amount: $1,990,130.00

    DESCRIPTION (provided by applicant): Renal cell therapy promises to improve the survival and overall health of patients suffering from acute renal failure (ARF), acute tubular necrosis (ATN), multiple ...

    SBIRPhase II2010Department of Health and Human Services
  7. Selective Cytopheresis Therapy in Systemic Inflammatory Response Syndrome

    Amount: $499,870.00

    DESCRIPTION (provided by applicant): An extracorporeal device, named selective cytopheretic device (SCD), has been fabricated that sequesters activated leukocytes and inhibits their release of inflamm ...

    SBIRPhase I2008Department of Health and Human Services
  8. Enhanced Propagation of Adult Human Renal Epithelial Cells

    Amount: $137,388.00

    DESCRIPTION (provided by applicant): Available therapies for renal failure continue to be suboptimal with associated mortality rates of over 50% for acute renal failure (ARF) and a life expectancy for ...

    SBIRPhase I2008Department of Health and Human Services
  9. Cell Therapy for Septic Shock

    Amount: $1,155,440.00

    DESCRIPTION (provided by applicant): Tissue engineering and cell therapy is a new and exciting approach to the treatment of acute and chronic diseases. The potential success of this therapeutic approa ...

    SBIRPhase II2008Department of Health and Human Services
  10. Renal Tubules for a Bioartificial Kidney: Monolayer Differentiation of ES Cells

    Amount: $249,999.00

    DESCRIPTION (provided by applicant): Over 400,000 people are currently being treated for End-Stage Renal Disease (ESRD) in the United States, with the number of patients expected to grow dramatically ...

    SBIRPhase I2007Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government